Respiratory Syncytial Virus Vaccines
"Respiratory Syncytial Virus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.
| Descriptor ID |
D022261
|
| MeSH Number(s) |
D20.215.894.899.730
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory Syncytial Virus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Respiratory Syncytial Virus Vaccines".
This graph shows the total number of publications written about "Respiratory Syncytial Virus Vaccines" by people in this website by year, and whether "Respiratory Syncytial Virus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 |
| 2025 | 3 | 0 | 3 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory Syncytial Virus Vaccines" by people in Profiles.
-
Sequential Safety Surveillance of RSVpreF Vaccination During Pregnancy Early in the Postapproval Period. JAMA Netw Open. 2026 04 01; 9(4):e266190.
-
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalink. Vaccine. 2025 Nov 20; 67:127873.
-
Respiratory syncytial virus vaccine uptake among adults aged =60?years in a large, integrated healthcare system in Southern California 2023-2024. Vaccine. 2025 Apr 19; 53:127033.
-
Knowledge About Respiratory Syncytial Virus and Acceptance of Infant Monoclonal Antibody for RSV and RSV Vaccination During Pregnancy. Pediatr Infect Dis J. 2025 Feb 01; 44(2S):S162-S166.
-
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Lancet. 2024 Oct 19; 404(10462):1547-1559.